1. Efficacy of a real-time intelligent quality-control system for the detection of early upper gastrointestinal neoplasms: a multicentre, single-blinded, randomised controlled trialResearch in context
- Author
-
Ruchen Zhou, Jing Liu, Chenchen Zhang, Yusha Zhao, Jingran Su, Qiong Niu, Chengxia Liu, Zhuang Guo, Zhenqin Cui, Xiaoqin Zhong, Weidong Zhao, Jing Li, Xiaodong Zhang, Hongyan Wang, Shidong Sun, Ruiguang Ma, Xinyu Chen, Xinyan Xu, Yiqing Zhu, Zhen Li, Xiuli Zuo, and Yanqing Li
- Subjects
Artificial intelligence ,Quality control ,Oesophagogastroduodenoscopy ,Gastrointestinal neoplasms ,Early gastric cancer ,Medicine (General) ,R5-920 - Abstract
Summary: Background: Oesophagogastroduodenoscopy (OGD) quality and identification of the early upper gastrointestinal (UGI) neoplasm play an important role in detecting the UGI neoplasm. However, the optimal method for quality control in daily OGD procedures is currently lacking. We aimed to evaluate the efficacy of a real-time intelligent quality-control system (IQCS), which combines OGD quality control with lesion detection of early UGI neoplasms. Methods: We performed a multicentre, single-blinded, randomised controlled trial at 6 hospitals in China. Patients aged 40–80 years old who underwent painless OGD were screened for enrolment in this study. Patients with a history of advanced UGI cancer, stenosis, or obstruction in UGI tract were excluded. Eligible subjects were randomly assigned (1:1) to either the routine or IQCS group to undergo standard OGD examination and OGD examination aided by IQCS, respectively. Patients were masked to the randomisation status. The primary outcome was the detection of early UGI neoplasms. All analyses were done on a per-protocol basis. This trial is registered with ClinicalTrials.gov, NCT04720924. Findings: Between January 16, 2021 and December 23, 2022, 1840 patients were randomised (IQCS group: 919, routine group: 921). The full analysis set consisted of 914 in the IQCS group and 915 in the routine group. The early UGI neoplasms detection rate in the IQCS group (6.1%, 56/914) was significantly higher than in the routine group (2.3%, 21/915; P = 0.0001). The IQCS group had fewer blind spots (2.3 vs. 6.2, P
- Published
- 2024
- Full Text
- View/download PDF